| Literature DB >> 27543143 |
Kai-Yu Huang1, Shuang Liang1, Mei-Ling Yu1, Shu-Ping Fu1,2, Xia Chen1, Sheng-Feng Lu3,4.
Abstract
BACKGROUND: Memory loss is the most prominent symptoms of brain aging, but there is currently no evidence-based treatment strategy. Acupuncture has been widely used in China and the effectiveness for improving learning and memory has been mentioned in previous studies. We conducted this systematic review and meta-analysis to evaluate the effectiveness of acupuncture for improving learning and memory in animal experiments.Entities:
Keywords: Acupuncture; Learning; Memory; Meta-analysis
Mesh:
Year: 2016 PMID: 27543143 PMCID: PMC4992193 DOI: 10.1186/s12906-016-1298-3
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Fig. 1Flow diagram of the study selection process for this systematic review and meta-analysis
Characteristics of the included studies
| Study | Species (Nc/Na) | Weight(g) | Age (month) | Model | Acupuncture (acupoints) | Control intervention | Outcome index |
|
|---|---|---|---|---|---|---|---|---|
| Bao 2014 [ | SD Rats (12/12) | 200 ± 20 | NR | PTSD (CMS) | Electroacupuncture 20 min/d for 21d, continuous waves of 2Hz of frequency and current density of 2 mA (GV20, GV29). | Fluoxetine | 1. escape latency | 1. |
| Zeng 2008 [ | Wistar Rats (10/10) | 250 ± 10 | NR | AD (D-gal, NaNO2) | Electroacupuncture 20 min/d for 60d, disperse- dense waves of 80/100 Hz of frequency (LI4, LR3). | Donepezil | 1. escape latency | 1. |
| Chen 2015 [ | SD Rats (13/14) | 230 ± 20 | NR | VD (4-VO) | Electroacupuncture 30 min/d for 7d, disperse- dense waves of 1/20 Hz of frequency (GV24, GV20). | NR | 1. escape latency | 1. |
| Chen 2006 [ | Wistar Rats (34/34) | NR | New- born | HIBD (closed space) | Manual acupuncture 20 min/d for 10d (GV20, GV14). | NR | 1. escape latency | 1. |
| Dai 2015 [ | AKR Rats (10/10) | 24.0 ± 3.5 | 6 | AD (SAMP8) | Manual acupuncture 10 min/d for 28d (GV20, SP10, BL17, BL23). | NR | 1. escape latency | 1. |
| Hou 2013 [ | SD Rats (10/10) | 220 ± 20 | NR | PTSD(SPS) | Electroacupuncture 30 min/d for 7d, continuous waves of 2Hz of frequency and current density of 1 mA (GV20, ST36). | NR | 1. escape latency | 1. |
| Gao 2012 [ | SD Rats (16/16) | 400–500 | 20–24 | AD(aged rats) | Electroacupuncture 30 min/d for 21d, disperse- dense waves of 2/100 Hz of frequency and intensity of 2–4 V (GV20, KI1). | NR | 1. swimming time | 1. |
| Huang 2010 [ | Wistar Rats (10/10) | 200 ± 20 | NR | PD (6-OH DA) | Electroacupuncture 30 min/d for 24d, continuous waves of 100Hz of frequency and current density of 0.5 mA (GV16,LR3). | Madopar | 1. escape latency | 1. |
| Ji 2011 [ | SD Rats (10/10) | 220–260 | NR | VD (4-VO) | Manual acupuncture 30 min/d for 30d (GV20, CV17, CV6, BL17, SP6). | NR | 1. escape latency | 1. |
| Jia 2011 [ | SD Rats (20/20) | 220 ± 20 | NR | VD (2-VO) | Electroacupuncture 20 min/d for 14d, continuous waves of 2Hz of frequency and intensity of 3 V (GV20, GV14). | NR | 1. escape latency | 1. |
| Wang 2012 [ | Wistar Rats (10/10) | 300 ± 10 | NR | AD(STZ) | Electroacupuncture for 28d (GV20, GV14, ST36). | NR | 1. escape latency | 1. |
| Lin 2008 [ | SD Rats (10/10) | 620 ± 80 | 12 | VD (2-VO) | Electroacupuncture 20 min/d for 30d, continuous waves of 2Hz of frequency and current density of 1–2 mA (GV20, GV14,BL23). | Sham acupuncture | 1. escape latency | 1. |
| Luo 2007 [ | SD Rats (14/14) | 200 ± 20 | NR | VD (4-VO) | Electroacupuncture 20 min/d for 15d, continuous waves of 150Hz of frequency and current density of 1 mA (GV20, BL17, BL20, BL23). | Nimodipine | 1. escape latency | 1. |
| Ma 2009 [ | Wistar Rats (13/13) | 200–250 | NR | Diabete (STZ) | Electroacupuncture 15 min/d for 14d, continuous waves of 0.5Hz of frequency and current density of 30 mA (GV20, GV14). | NR | 1. escape latency | 1. |
| Zhang 2014 [ | AKR Rats (10/10) | NR | 4 | AD (SAMP8) | Manual acupuncture 30 min/d for 30d, twisting 10 s a time (GV20,ST36). | NR | 1. escape latency | 1. |
| Niu 2009 [ | SD Rats (10/10) | 300 ± 20 | NR | VD (4-VO) | Electroacupuncture 10 min/d for 42d, disperse- dense waves of 80/100 Hz of frequency and current density of 1–3 mA (GV29, LI20). | NR | 1. escape latency | 1. |
| Su 2013 [ | SD Rats (12/12) | 200–250 | NR | AD(D-gal, Aβ1- 42) | Electroacupuncture 15 min/d for 28d, continuous waves of 35Hz of frequency and intensity of 2 V (GV20, KI3, ST36). | NR | 1. escape latency | 1. |
| Tan 2014 [ | Wistar Rats (8/8) | 250 ± 50 | 2 | VD (MCAO) | Electroacupuncture 15 min/d for 21d, continuous waves of 16Hz of frequency and current density of 1 mA (GV20, GV14). | NR | 1. escape latency | 1. |
| Tang 2014 [ | SD Rats (10/10) | 160–200 | 3 | OVX | Electroacupuncture 20 min/d for 45d, continuous waves of 3–4Hz of frequency and current density of 4–5 mA (ST36, BL23). | Sham acupuncture | 1. escape latency | 1. |
| Wang 2013 [ | SD Rats (10/10) | 200 ± 20 | NR | AD (D-gal, NaNO2) | Manual acupuncture 10 min/d for 30d (LI4, LR3, ST36). | Donepezil | 1. escape latency | 1. |
| Wang 2009 [ | SD Rats (12/13) | 240 ± 20 | 3 | VD (2-VO) | Manual acupuncture 10 min/d for 30d (GV20, BL17, CV6, SP6, CV17). | Piracetam | 1. escape latency | 1. |
| Hong 2014 [ | Wistar Rats (10/10) | 300–350 | NR | Autism (VPA) | Manual acupuncture 1 min/d for 30d (GV1). | Sham acupuncture | 1. escape latency | 1. |
| Xu 2006 [ | SD Rats (13/14) | 200–220 | 2 | VD (4-VO) | Electroacupuncture 20 min/d for 20d, continuous waves of 150Hz of frequency and current density of 20 mA (GV20, GV14). | Nimodipine | 1. escape latency | 1. |
| Xu 2007 [ | SD Rats (8/10) | 180–200 | NR | AD (D-gal) | Electroacupuncture 20 min/d for 21d, continuous waves of 3Hz of frequency and current density of 1 mA (GV20, ST36). | NR | 1. escape latency | 1. |
| Yi 2014 [ | SD Rats (12/12) | 200 ± 34 | 4 | AD (Aβ25–35) | Electroacupuncture 30 min/d for 12d, disperse- dense waves of 2/30 Hz of frequency and current density of 1 mA (GV29, LI20). | NR | 1. escape latency | 1. |
| Yu 2014 [ | Wistar Rats (10/10) | 200–250 | NR | WD (CuSO4) | Electroacupuncture 15 min/d for 7d, continuous waves of 2Hz of frequency and current density of 1 mA (HT7). | NR | 1. escape latency | 1. |
| Feng 2013 [ | AKR Rats (10/9) | 29–35 | 9 | AD (SAMP8) | Manual acupuncture 20 min/d for 28d, twisting 2.5 times/s for 60 s(GV20, KI1). | NR | 1. escape latency | 1. |
| Li 2013 [ | Wistar Rats (10/10) | 200–250 | 4 | AD(STZ) | Electroacupuncture for 28d, continuous waves of 30Hz of frequency and intensity of 2 V (BL23, KI3, ST36, GV20, GV14). | Donepezil | 1. escape latency | 1. |
| Wang 2013 [ | AKR Rats (10/10) | NR | 8 | AD (SAMP8) | Manual acupuncture for 15d (CV17, CV12, CV6, SP10,ST36). | Sham acupuncture | 1. escape latency | 1. |
| Zheng 2009 [ | Wistar Rats (8/7) | 212 ± 15 | 2 | VD (2-VO) | Electroacupuncture for 28d, continuous waves of 2Hz of frequency (GV20, KI3). | NR | 1. escape latency | 1. |
| Li 2012 [ | AKR Rats (15/15) | NR | 7.5 | AD (SAMP8) | Manual acupuncture for 15d, twisting 2 times/s for 30 s (CV17, CV12, CV6, SP10, ST36). | Sham acupuncture | 1. escape latency | 1. |
| Li 2014 [ | C57BL/6 Rats (6/6) | NR | 2 | AD (APP/PS1) | Electroacupuncture 30 min/d for 20d, disperse- dense waves of 2/15 Hz of frequency and current density of 1 mA (GV20). | NR | 1. escape latency | 1. |
| Lee 2014 [ | SD Rats (7/7) | 220–240 | NR | AD(SCO) | Manual acupuncture for 15d (GV20). | Sham acupuncture | 1. escape latency | 1. |
| Zhu 2013 [ | SD Rats (6/6) | 432 ± 30 | 12 | VD (2-VO) | Electroacupuncture 20 min/d for 30d, continuous waves of 4Hz of frequency and current density of 2 mA (GV20, GV14, BL23). | NR | 1. escape latency | 1. |
| Lu 2014 [ | SD Rats (8/8) | 200–250 | NR | Ethanol | Electroacupuncture 20 min/d for 30d, continuous waves of 2Hz of frequency and current density of 1.5–2 mA (ST36). | Sham acupuncture | 1. escape latency | 1. |
| Li 2012 [ | SD Rats (10/10) | 250 ± 30 | 3 | VD (MCAO) | Electroacupuncture 30 min/d for 14d, disperse- dense waves of 2/30 Hz of frequency and current density of 2 mA (GV20, GV14). | NR | 1. escape latency | 1. |
| Guo 2015 [ | SD Rats (10/10) | 250–300 | NR | AD (Aβ1–40) | Electroacupuncture 30 min/d for 24d, continuous waves of 20Hz of frequency and current density of less than 2 mA (GV20, BL23). | Sham acupuncture | 1. escape latency | 1. |
| Jiang 2015 [ | AKR Rats (10/10) | NR | 7.5 | AD (SAMP8) | Electroacupuncture for 14d, continuous waves of 2Hz of frequency,current density of 0.6 mA and intensity of 2 V (GV20,GV26, GV29). | NR | 1. escape latency | 1. |
| Shao 2008 [ | SD Rats (8/9) | 180–220 | NR | VD (4-VO) | Electroacupuncture 20 min/d for 15d, continuous waves of 150Hz of frequency and current density of 1–2 mA (GV20, BL17, BL20, BL23). | Nimodipine | 1. escape latency | 1. |
| Liu 2013 [ | SD Rats (12/12) | 200 ± 20 | NR | CFS | Manual acupuncture 20 min/d for 21d, twirling reinforcing (ST36). | NR | 1. escape latency | 1. |
| Li 2015 [ | Wistar Rats (11/11) | 320–360 | NR | VD(micro- emboli) | Manual acupuncture for 12d, twisting 2 times/s for 30 s (ST36). | Sham acupuncture | 1. escape latency | 1. |
| Lu 2008 [ | AKR Rats (12/12) | 20 ± 2 | 8 | AD (SAMP8) | Electroacupuncture 20 min/d for 7d, disperse- dense waves of 2/100 Hz of frequency and intensity of 2–4 V (GV20, KI1). | NR | 1. escape latency | 1. |
Nc animal number in control group, Na animal number in acupuncture group, PTSD post-traumatic stress disorder, CMS chronic mild stimulation, NR not report, AD Alzheimer’s disease, VD vascular dementia, 4-VO 4- vessel occlusion, SPS single prolonged stress, PD Parkinson’s disease, 6-OHDA 6-OH-dopamine, STZ streptozotocin, CFS chronic fatigue syndrome, MCAO middle cerebral artery occlusion, OVX ovariectomy, VPA sodium valproate, WD Wilson disease
Risk of bias of included studies
| Study | (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bao 2014 [ | √ | √ | √ | √ | √ | √ | 6 | ||||
| Zeng 2008 [ | √ | √ | √ | √ | 4 | ||||||
| Chen 2015 [ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
| Chen 2006 [ | √ | √ | √ | √ | √ | 5 | |||||
| Dai 2015 [ | √ | √ | √ | √ | √ | 5 | |||||
| Hou 2013 [ | √ | √ | √ | √ | √ | 5 | |||||
| Gao 2012 [ | √ | √ | √ | √ | 4 | ||||||
| Huang 2010 [ | √ | √ | √ | √ | 4 | ||||||
| Ji 2011 [ | √ | √ | √ | √ | 4 | ||||||
| Jia 2011 [ | √ | √ | √ | √ | 4 | ||||||
| Wang 2012 [ | √ | √ | √ | √ | √ | √ | 6 | ||||
| Lin 2008 [ | √ | √ | √ | √ | 4 | ||||||
| Luo 2007 [ | √ | √ | 2 | ||||||||
| Ma 2009 [ | √ | √ | √ | √ | √ | 5 | |||||
| Zhang 2014 [ | √ | √ | √ | √ | √ | 5 | |||||
| Niu 2009 [ | √ | √ | √ | √ | 4 | ||||||
| Su 2013 [ | √ | √ | √ | 3 | |||||||
| Tan 2014 [ | √ | √ | √ | √ | √ | √ | √ | 7 | |||
| Tang 2014 [ | √ | √ | √ | 3 | |||||||
| Wang 2013 [ | √ | √ | √ | √ | 4 | ||||||
| Wang 2009 [ | √ | √ | √ | √ | 4 | ||||||
| Hong 2014 [ | √ | √ | √ | √ | √ | √ | 6 | ||||
| Xu 2006 [ | √ | √ | √ | √ | 4 | ||||||
| Xu 2007 [ | √ | √ | √ | √ | √ | 5 | |||||
| Yi 2014 [ | √ | √ | √ | √ | √ | √ | 6 | ||||
| Yu 2014 [ | √ | √ | √ | √ | √ | 5 | |||||
| Feng 2013 [ | √ | √ | √ | √ | √ | 5 | |||||
| Li 2013 [ | √ | √ | √ | √ | 4 | ||||||
| Wang 2013 [ | √ | √ | √ | √ | √ | √ | 6 | ||||
| Zheng 2009 [ | √ | √ | √ | 3 | |||||||
| Li 2012 [ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
| Li 2014 [ | √ | √ | √ | √ | √ | √ | √ | 7 | |||
| Lee 2014 [ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
| Zhu 2013 [ | √ | √ | √ | √ | √ | √ | 6 | ||||
| Lu 2014 [ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
| Li 2012 [ | √ | √ | √ | √ | √ | 5 | |||||
| Guo 2015 [ | √ | √ | √ | √ | √ | √ | 6 | ||||
| Jiang 2015 [ | √ | √ | √ | √ | √ | √ | √ | 7 | |||
| Shao 2008 [ | √ | √ | √ | √ | √ | 5 | |||||
| Liu 2013 [ | √ | √ | √ | √ | √ | 5 | |||||
| Li 2015 [ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
| Lu 2008 [ | √ | √ | √ | √ | 4 |
(1) publication in a peer-reviewed journal; (2) statements describing control of temperature; (3) random allocation to treatment or control; (4) blinded building of model; (5) assessment whether building model is successful; (6) blinded assessment of outcome;(7) use of anesthetic without significant intrinsic neuroprotective activity; (8) sample size calculation; (9) compliance with animal welfare regulations; (10) declared any potential conflict of interest
Fig. 2Pooled estimate of decreasing escape latency with acupuncture
Fig. 3Pooled estimate of increasing frequency of cross platform with acupuncture
Fig. 4Pooled estimate of increasing time in target quadrant with acupuncture
Summary of proposed mechanisms
| Study | Findings or proposed mechanisms |
|---|---|
| Bao 2014 [ | • Reduced apoptosis of hippocampal neurons |
| Chen 2015 [ | • Reduced Nogo-A and NgR |
| Chen 2006 [ | • Increased GABA |
| Dai 2015 [ | • Increased NEP |
| Hou 2013 [ | • Increased MR |
| Gao 2012 [ | • Increased DA, 5-HT and NE |
| Huang 2010 [ | • Increased BDNF |
| Ji 2011 [ | • Reduced MDA |
| Jia 2011 [ | • Increased Syp, PKC, NMDAR and PKC mRNA |
| Wang 2012 [ | • Increased NOS |
| Lin 2008 [ | • Increased NMDAR-2BmRNA |
| Luo 2007 [ | • Decreased NO |
| Ma 2009 [ | • Increased CTGF protein and mRNA |
| Zhang 2014 [ | • Increased InsR mRNA |
| Niu 2009 [ | • Increased SS and AVP |
| Su 2013 [ | • Reduced MDA, P53 and P21 |
| Tan 2014 [ | • Increased GAP-43 and c-fos |
| Tang 2014 [ | • Increased CHAT protein |
| Wang 2013 [ | • Reduced GSK-3β |
| Wang 2009 [ | • Reduced ET |
| Hong 2014 [ | • Increased CX43, CX32 and CX36 |
| Xu 2006 [ | • Increased Bcl-2 protein |
| Xu 2007 [ | • Reduced IL-1β and TNF-α |
| Yi 2014 [ | • Increased SOD, PKA and pCREB |
| Feng 2013 [ | • Increased GluR2 |
| Li 2013 [ | • Reduced MMP-2 and MMP-9 |
| Zheng 2009 [ | • Increased ChAT |
| Li 2012 [ | • Reduced neuron loss |
| Li 2014 [ | • Increased BDNF |
| Lee 2014 [ | • Stimulated cholinergic enzyme activities |
| Zhu 2013 [ | • Up-regulated mTOR and eIF4E |
| Lu 2014 [ | • Increased Fos expression |
| Li 2012 [ | • increased Bcl-2mRNA |
| Guo 2015 [ | • Down-regulated Notch1 and Hes1 mRNA |
| Jiang 2015 [ | • Increased the level of uptake rate of glucose |
| Shao 2008 [ | • Regulated the amount of AVP, SS, and β-EP |
| Liu 2013 [ | • Reduced MDA |
| Li 2015 [ | • Increased the pyramidal neuron number |
| Lu 2008 [ | • Increased NCAM and ST8SiaII/IVmRNA |
Nogo-A neurite growth inhibitor-A, NgR neurite growth inhibitor receptor, GABA γ-aminobutyric acid, Glu glutamic acid, NEP neutral endopeptidase, MR mineralocorticoid receptor, GR glucocorticoid receptor, DA dopamine, 5-HT 5-hydroxytryptamine, NE norepinephrine, BDNF brain-derived neurotrophic factor, MDA malondialdehyde, SOD superoxide dismutase, SYP synaptophysin, PKC Protein kinase C, NMDAR N-methyl-D-aspartate receptor, mGluRs metabolism glutanic acid acceptor, NOS nitric oxide synthase, MAO monoamine oxidase, NO nitric oxide, CTGF connective tissue growth factor, InsR insulin receptor, SS somatostatin, AVP arginine vasopressin, GAP-43 Growth Associated Protein-43, CHAT choline acetyl transferase, GSK-3β glycogen synthase kinase-3β, ET endothelia, CGRP calcitonin gene-related peptide, CX connexin, IL interleukin, TNF tumor necrosis factor, pCREB phosphorylated cAMP-response element binding, MMP metal matrix proteinase, ChAT choline acetyltransferase, TchE total cholinesterase, CREB cAMP response element-binding protein, mTOR mammalian target of rapamycin, eIF4E eukaryotic translation initiation factor 4E, NCAM neural cell adhesion molecule
Fig. 5Funnel plot for effectiveness of acupuncture on escape latency, frequency of cross platform and time in target quadrant
Fig. 6Subgroup analysis according to escape latency. a The effect of manual acupuncture and electroacupuncture on the estimate of improvement in escape latency. b The impact of published articles compared with unpublished articles on the estimate of improvement in escape latency. c The type of strain on the estimate of improvement in escape latency. d The sensitiveness of AD model compared with VD model on the estimate of improvement in escape latency. e The different ways making AD model on the estimate of improvement in escape latency. f The different ways making VD model on the estimate of improvement in escape latency. g The different weights on the estimate of improvement in escape latency. h The different age on the estimate of improvement in escape latency
Fig. 7Subgroup analysis according to frequency of cross platform. a The effect of manual acupuncture and electroacupuncture on the estimate of improvement in frequency of cross platform. b The impact of published articles compared with unpublished articles on the estimate of improvement in frequency of cross platform. c The type of strain on the estimate of improvement in frequency of cross platform. d The sensitiveness of AD model compared with VD model on the estimate of improvement in frequency of cross platform. e The different ways making AD model on the estimate of improvement in frequency of cross platform. f The different ways making VD model on the estimate of improvement in frequency of cross platform. g The different weights on the estimate of improvement in frequency of cross platform. h The different age on the estimate of improvement in frequency of cross platform
Fig. 8Subgroup analysis according to time in target quadrant. a The effect of manual acupuncture and electroacupuncture on the estimate of improvement in time in target quadrant. b The type of strain on the estimate of improvement in time in target quadrant. c The sensitiveness of AD model compared with VD model on the estimate of improvement in time in target quadrant. d The different ways making AD model on the estimate of improvement in time in target quadrant. e The different weights on the estimate of improvement in time in target quadrant. f The different age on the estimate of improvement in time in target quadrant